Research Compound Profile

PT-141 (Bremelanotide): Research Profile (November 2026)

PT-141 (bremelanotide) is a cyclic heptapeptide analogue of α-MSH that acts as a melanocortin receptor agonist, studied for central nervous system melanocortin signalling.

For laboratory research and educational purposes only. This profile summarizes published preclinical and analytical literature and is not medical advice or dosing guidance.

Research-Grade PT-141

Supplied as PT-141 (Bremelanotide) 10mg with a batch-specific HPLC and mass spectrometry COA — verify any batch.

Further Reading

Other Compound Profiles